Carter Eric G

Director at AEON Biopharma, Inc. · on record since Jul 24, 2023
Chief Science Officer at KING PHARMACEUTICALS INC · on record since Jan 26, 2007
Director at Avalanche Biotechnologies, Inc. · on record since Sep 8, 2017
Interim Chief Medical Officer at ALDER BIOPHARMACEUTICALS INC · on record since Apr 25, 2018

Insider trading activity of Carter Eric G

Transactions on record: 49; since Jan 26, 2007

Open-market buys: 0

Open-market sells: 0

Companies traded: 4; last filing Jun 22, 2026

Figures computed from official regulatory filings — methodology.

Companies where Carter Eric G has traded

AEON Biopharma, Inc.9 tx · Jun 22, 2026
Avalanche Biotechnologies, Inc.5 tx · Jun 25, 2020
ALDER BIOPHARMACEUTICALS INC1 tx · Apr 25, 2018
KING PHARMACEUTICALS INC34 tx · $703.3K · Feb 2, 2011

Track record of Carter Eric G

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Carter Eric G

Co-insiders of Carter Eric G

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
AEON Biopharma, Inc.	Jun 22, 2026	Award	222,684	0.00 USD	—	SEC
AEON Biopharma, Inc.	May 23, 2025	AwardD	308,641	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Sep 4, 2024	Award	36,021	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Sep 4, 2024	AwardD	96,210	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Mar 21, 2024	AwardD	16,260	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Mar 21, 2024	AwardD	8,130	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Aug 16, 2023	AwardD	58,851	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Jul 24, 2023	AwardD	9,007	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Jul 24, 2023	AwardD	11,802	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Jun 25, 2020	AwardD	30,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Aug 2, 2019	AwardD	45,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Jun 15, 2018	AwardD	35,000	0.00 USD	$0	SEC
ALDER BIOPHARMACEUTICALS INC	Apr 25, 2018	AwardD	75,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Sep 8, 2017	Award	48,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Sep 8, 2017	AwardD	69,000	0.00 USD	$0	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	Other	-135,427	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-17,860	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-55,740	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-34,240	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-42,240	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	Other	-38,740	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-50,290	—	—	SEC
KING PHARMACEUTICALS INC	Jan 20, 2011	Exercise	37,940	0.00 USD	$0	SEC
KING PHARMACEUTICALS INC	Jan 20, 2011	AwardD	17,860	0.00 USD	$0	SEC
KING PHARMACEUTICALS INC	Jan 20, 2011	ExerciseD	-37,940	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
AEON Biopharma, Inc.	Jun 22, 2026	Award	222,684	0.00 USD	—	SEC
AEON Biopharma, Inc.	May 23, 2025	AwardD	308,641	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Sep 4, 2024	Award	36,021	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Sep 4, 2024	AwardD	96,210	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Mar 21, 2024	AwardD	16,260	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Mar 21, 2024	AwardD	8,130	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Aug 16, 2023	AwardD	58,851	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Jul 24, 2023	AwardD	9,007	0.00 USD	$0	SEC
AEON Biopharma, Inc.	Jul 24, 2023	AwardD	11,802	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Jun 25, 2020	AwardD	30,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Aug 2, 2019	AwardD	45,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Jun 15, 2018	AwardD	35,000	0.00 USD	$0	SEC
ALDER BIOPHARMACEUTICALS INC	Apr 25, 2018	AwardD	75,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Sep 8, 2017	Award	48,000	0.00 USD	$0	SEC
Avalanche Biotechnologies, Inc.	Sep 8, 2017	AwardD	69,000	0.00 USD	$0	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	Other	-135,427	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-17,860	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-55,740	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-34,240	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-42,240	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	Other	-38,740	—	—	SEC
KING PHARMACEUTICALS INC	Feb 2, 2011	OtherD	-50,290	—	—	SEC
KING PHARMACEUTICALS INC	Jan 20, 2011	Exercise	37,940	0.00 USD	$0	SEC
KING PHARMACEUTICALS INC	Jan 20, 2011	AwardD	17,860	0.00 USD	$0	SEC
KING PHARMACEUTICALS INC	Jan 20, 2011	ExerciseD	-37,940	0.00 USD	$0	SEC